Effects of a synbiotic yogurt using monk fruit extract as sweetener on glucose regulation and gut microbiota in rats with type 2 diabetes mellitus

Journal of Dairy Science

Volumn 103, Issue 4, 2020, Pages 2956-2968

  Ban, Qingfeng ^a   Cheng, Jianjun ^a   Sun, Xiaomeng ^a   Jiang, Yunqing ^a   Zhao, Shanbo ^a   Song, Xiao ^a   Guo, Mingruo ^a,b  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

gut microbiota; monk fruit extract; synbiotic yogurt; type 2 diabetes mellitus

Indexed keywords

PLANT EXTRACT; SWEETENING AGENT; SYNBIOTIC AGENT; YOGHURT;

ANIMAL; CHEMISTRY; CUCURBITACEAE; DRUG EFFECT; FRUIT; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; LIVER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; CUCURBITACEAE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FRUIT; GASTROINTESTINAL MICROBIOME; INSULIN RESISTANCE; LIVER; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SWEETENING AGENTS; SYNBIOTICS; YOGURT;

EID: 85080048602     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2019-17700     Document Type: Article

References (53)

1. Ali, S., Drucker, D.J., Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E415–E421 10.1152/ajpendo.90887.2008 19116373.
2. Bender, S.B., Mcgraw, A.P., Jaffe, I.Z., Sowers, J.R., Mineralocorticoid receptor-mediated vascular insulin resistance: An early contributor to diabetes-related vascular disease. Diabetes 62 (2013), 313–319 10.2337/db12-0905 23349535.
3. Bordalo Tonucci, L., Dos Santos, K.M.O., De Luces Fortes Ferreira, C.L., Ribeiro, S.M.R., De Oliveira, L.L., Martino, H.S.D., Gut microbiota and probiotics: Focus on diabetes mellitus. Crit. Rev. Food Sci Nutr. 57 (2017), 2296–2309 10.1080/10408398.2014.934438 26499995.
4. Chakrabarti, R., Rajagopalan, R., Diabetes and insulin resistance associated disorders: Disease and the therapy. Curr. Sci. 83 (2002), 1533–1538.
5. Chen, L., Zhao, H., Zhang, C., Lu, Y., Zhu, X., Lu, Z., γ-aminobutyrate-rich yogurt fermented by Streptococcus salivarius ssp. thermophiles fmb5 appears to have anti-diabetic effect on streptozotocin-induced diabetic mice. J. Funct. Foods 20 (2016), 267–275 10.1016/j.jff.2015.10.030.
6. Chen, W.J., Song, F.F., Liu, L.G., Qi, X.Y., Xie, B.J., Song, Y.F., Effects of mogroside extract on cellular immune functions in alloxan-induced diabetic rats. Acta Nutr. Sin. 28 (2006), 221–225.
7. De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., Mithieux, G., Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (2014), 84–96 10.1016/j.cell.2013.12.016 24412651.
8. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J., Paquot, N., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105 (2014), 141–150 10.1016/j.diabres.2014.04.006 24798950.
9. Fox, C.S., Golden, S.H., Anderson, C., Bray, G.A., Burke, L.E., De Boer, I.H., Deedwania, P., Eckel, R.H., Ershow, A.G., Fradkin, J., Inzucchi, S.E., Kosiborod, M., Nelson, R.G., Patel, M.J., Pignone, M., Quinn, L., Schauer, P.R., Selvin, E., Vafiadis, D.K., Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38 (2015), 1777–1803 10.2337/dci15-0012 26246459.
10. Gao, Z., Yin, J., Zhang, J., Ward, R.E., Martin, R.J., Lefevre, M., Cefalu, W.T., Ye, J., Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58 (2009), 1509–1517 10.2337/db08-1637 19366864.
11. Gijsbers, L., Ding, E.L., Malik, V.S., de Goede, J., Geleijnse, J.M., Soedamah-Muthu, S.S., Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 103 (2016), 1111–1124 10.3945/ajcn.115.123216 26912494.
12. Howard, B.V., Wylierosett, J., Sugar and cardiovascular disease a statement for health care professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 106 (2002), 523–527 10.1161/01.CIR.0000019552.77778.04 12135957.
13. International Diabetes Federation, IDF Diabetes Atlas. 8th ed. International Diabetes Federation, Brussels, Belgium. http://www.diabetesatlas.org/resourc es/2017-atlas.html, 2017.
14. Jia, L., Li, D., Feng, N., Shamoon, M., Sun, Z., Ding, L., Zhang, H., Chen, W., Sun, J., Chen, Y.Q., Anti-diabetic effects of Clostridium butyricum CGMCC0313.1 through promoting the growth of gut butyrate-producing bacteria in type 2 diabetic mice. Sci. Rep., 7, 2017, 7046 10.1038/s41598-017-07335-0 28765642.
15. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C.J., Fagerberg, B., Nielsen, J., Backhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103 10.1038/nature12198 23719380.
16. Kim, B., Feldman, E.L., Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp. Mol. Med., 47, 2015, e149 10.1038/emm.2015.3 25766618.
17. Kinghorn, A.D., Kaneda, N., Baek, N.I., Kennelly, E.J., Soejarto, D.D., Noncariogenic intense natural sweeteners. Med. Res. Rev. 18 (1998), 347–360 10.1002/(SICI)1098-1128(199809)18:5347::AID-MED53.0.CO;2-T 9735874.
18. Larsen, N., Vogensen, F.K., van den Berg, F.W.J., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., Sørensen, S.J., Hansen, L.H., Jakobsen, M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5, 2010, e9085 10.1371/journal.pone.0009085 20140211.
19. Li, C., Lin, L.M., Sui, F., Wang, Z.M., Huo, H.R., Dai, L., Jiang, T.L., Chemistry and pharmacology of Siraitia grosvenorii: A review. Chin. J. Nat. Med. 12 (2014), 89–102 10.1016/S1875-5364(14)60015-7 24636058.
20. Lin, G.P., Jiang, T., Hu, X.B., Qiao, X.H., Tuo, Q.H., Effect of Siraitia grosvenorii polysaccharide on glucose and lipid of diabetic rabbits induced by feeding high fat/high sucrose chow. Exp. Diabetes Res., 2007, 2007, 67435 10.1155/2007/67435 18273381.
21. Liu, H., Qi, X., Yu, K., Lu, A., Lin, K., Zhu, J., Zhang, M., Sun, Z., AMPK activation is involved in hypoglycemic and hypolipidemic activities of mogroside-rich extract from Siraitia grosvenorii (swingle) fruits on high-fat diet/streptozotocin-induced diabetic mice. Food Funct. 10 (2019), 151–162 10.1039/C8FO01486H 30516208.
22. Louis, P., Scott, K.P., Duncan, S.H., Flint, H.J., Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol. 102 (2007), 1197–1208 10.1111/j.1365-2672.2007.03322.x 17448155.
23. Lu, A.M., Zhang, Z.Y., The genus Siraitia Merr. in China. Guihaia 4 (1984), 27–33.
24. Mao, B., Li, D., Zhao, J., Liu, X., Gu, Z., Chen, Y.Q., Zhang, H., Chen, W., Metagenomic insights into the effects of fructo-oligosaccharides (fos) on the composition of fecal microbiota in mice. J. Agric. Food Chem. 63 (2015), 856–863 10.1021/jf505156h 25598242.
25. Morrison, D.J., Preston, T., Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (2016), 189–200 10.1080/19490976.2015.1134082 26963409.
26. Moure, A., Gullón, P., Domínguez, H., Parajó, J.C., Advances in the manufacture, purification and applications of xylo-oligosaccharides as food additives and nutraceuticals. Process Biochem. 41 (2006), 1913–1923 10.1016/j.procbio.2006.05.011.
27. Murphy, S.P., Johnson, R.K., The scientific basis of recent US guidance on sugars intake. Am. J. Clin. Nutr. 78 (2003), 827S–833S 10.1093/ajcn/78.4.827S 14522746.
28. Nathan, D.M., DCCT/EDIC Research Group, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: Overview. Diabetes Care 37 (2014), 9–16.
29. Qi, X.Y., Chen, W.J., Liu, L.G., Yao, P., Xie, B.J., Effect of a Siraitia grosvenori extract containing mogrosides on the cellular immune system of type 1 diabetes mellitus mice. Mol. Nutr. Food Res. 50 (2006), 732–738 10.1002/mnfr.200500252 16835866.
30. Qi, X.Y., Chen, W.J., Zhang, L.Q., Xie, B.J., Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice. Nutr. Res. 28 (2008), 278–284 10.1016/j.nutres.2008.02.008 19083420.
31. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., Peng, Y., Zhang, D., Jie, Z., Wu, W., Qin, Y., Xue, W., Li, J., Han, L., Lu, D., Wu, P., Dai, Y., Sun, X., Li, Z., Tang, A., Zhong, S., Li, X., Chen, W., Xu, R., Wang, M., Feng, Q., Gong, M., Yu, J., Zhang, Y., Zhang, M., Hansen, T., Sanchez, G., Raes, J., Falony, G., Okuda, S., Almeida, M., LeChatelier, E., Renault, P., Pons, N., Batto, J.-M., Zhang, Z., Chen, H., Yang, R., Zheng, W., Li, S., Yang, H., Wang, J., Ehrlich, S.D., Nielsen, R., Pedersen, O., Kristiansen, K., Wang, J., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60 10.1038/nature11450 23023125.
32. Qu, L., Ren, J., Huang, L., Pang, B., Liu, X., Liu, X., Li, B., Shan, Y., Antidiabetic effects of Lactobacillus casei fermented yogurt through reshaping gut microbiota structure in Type 2 diabetic rats. J. Agric. Food Chem. 66 (2018), 12696–12705 10.1021/acs.jafc.8b04874 30398060.
33. Shi, D., Zheng, M., Wang, Y., Liu, C., Chen, S., Protective effects and mechanisms of mogroside V on lps-induced acute lung injury in mice. Pharm. Biol. 52 (2014), 729–734 10.3109/13880209.2013.867451 24621273.
34. Shin, N.R., Lee, J.C., Lee, H.Y., Kim, M.S., Whon, T.W., Lee, M.S., Bae, J.-W., An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (2014), 727–735 10.1136/gutjnl-2012-303839 23804561.
35. Stephens, J.W., Khanolkar, M.P., Bain, S.C., The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202 (2009), 321–329 10.1016/j.atherosclerosis.2008.06.006 18640680.
36. Suzuki, Y.A., Tomoda, M., Murata, Y., Inui, H., Sugiura, M., Nakano, Y., Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto–Kakizaki rat. Br. J. Nutr. 97 (2007), 770–775 10.1017/S0007114507381300 17349091.
37. Takasaki, M., Konoshima, T., Murata, Y., Sugiura, M., Nishino, H., Tokuda, H., Matsumoto, K., Kasai, R., Yamasaki, K., Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Lett. 198 (2003), 37–42 10.1016/S0304-3835(03)00285-4 12893428.
38. Tuepker, J., Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation, 107, 2003, e109 10.1161/01.CIR.0000067693.46108.2D 12719295.
39. Tura, A., Kautzky-Willer, A., Pacini, G., Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT. Diabetes Res. Clin. Pract. 72 (2006), 298–301 10.1016/j.diabres.2005.10.005 16325298.
40. Umar, A., Ahmed, Q.U., Muhammad, B.Y., Dogarai, B.B.S., Soad, S.Z.B.M., Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats. J. Ethnopharmacol. 131 (2010), 140–145.
41. Unger, R. H, Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28 (1985), 574–578 10.1007/BF00281991 3902546.
42. Unger, R.H., Aguilar-Parada, E., Müller, W.A., Eisentraut, A.M., Studies of pancreatic alpha cell function in normal and diabetic subjects. J. Clin. Invest. 49 (1970), 837–848 10.1172/JCI106297 4986215.
43. USDA, Yogurt, plain, whole milk. Agricultural Research Service National Nutrient Database for Standard Reference. Accessed March 12, 2019. https://ndb.nal.usda.gov/ndb/foods/show/01116, 2019.
44. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., Sitaraman, S.V., Knight, R., Ley, R.E., Gewirtz, A.T., Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328 (2010), 228–231 10.1126/science.1179721 20203013.
45. Wang, Q., Qin, H.H., Wang, W., The pharmacological research progress of Siraitiagrosvenorii. J. Guangxi Tradit. Chin. Med. Univ. 13 (2010), 75–76.
46. Wang, W.B., Bao, Y.H., Hendricks, G.M., Guo, M.R., Consistency, microstructure and probiotic survivability of goats' milk yoghurt using polymerized whey protein as a co-thickening agent. Int. Dairy J. 24 (2012), 113–119 10.1016/j.idairyj.2011.09.007.
47. World Health Organization, Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, 2009, World Health Organization, Geneva, Switzerland.
48. Xu, F., Li, D.P., Huang, Z.C., Lu, F.L., Wang, L., Huang, Y.L., Wang, R.-F., Liu, G.-X., Shang, M.-Y., Cai, S.-Q., Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by hplc-esi-it-tof-ms(n). J. Pharm. Biomed. Anal. 115 (2015), 418–430 10.1016/j.jpba.2015.07.024 26280925.
49. Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., Zhao, L., Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci. Rep., 5, 2015, 14405 10.1038/srep14405 26396057.
50. Zhang, Y., Guo, X., Guo, J., He, Q., Li, H., Song, Y., Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx. Sci. Rep., 4, 2014, 5654 25133590.
51. Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y.Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., Yu, L., Xu, C., Ren, Z., Xu, Y., Xu, S., Shen, H., Zhu, X., Shi, Y., Shen, Q., Dong, W., Liu, R., Ling, Y., Zeng, Y., Wang, X., Zhang, Q., Wang, J., Wang, L., Wu, Y., Zeng, B., Wei, H., Zhang, M., Peng, Y., Zhang, C., Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359 (2018), 1151–1156 10.1126/science.aao5774 29590046.
52. Zhou, G., Zhang, Y., Li, Y., Wang, M., Li, X., The metabolism of a natural product mogroside V, in healthy and type 2 diabetic rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1079 (2018), 25–33 10.1016/j.jchromb.2018.02.002 29428672.
53. Zhou, Y., Zheng, Y., Ebersole, J., Huang, C., Insulin secretion stimulating effects of mogroside v and fruit extract of luo han kuo (siraitia grosvenori swingle) fruit extract. Yao Xue Xue Bao, 44, 2009, 1252 21351724.